### Educational Background

- ​**2012.09—2017.06**  
  Southern Medical University, Bachelor's Degree  

- ​**2017.09—2020.06**  
  Southern Hospital, Department of Radiation Oncology  
  Master of Science (Oncology)  
  Supervisor: Prof. Yi Ding  

- ​**2021.09—2023.06**  
  Southern Hospital, Department of Radiation Oncology  
  Ph.D. (Oncology)  
  Supervisor: Prof. Yi Ding  

- ​**2023.07—Present**  
  Southern Hospital, Postdoctoral Fellow  

---

### Research Focus

- ​**Gut microbiota and radiation injury protection** (intestinal injury, bone marrow suppression)  
- ​**Radiotherapy sensitization in colorectal cancer**  

---

### Academic Achievements

#### ​**Publications**  
5 first/co-first author SCI papers (1 Q1, 3 Q2), 11 total SCI publications. ​**7 manuscripts under review** (3 in revision: 2 Q1, 1 Q2):  
1. ​**TXN Inhibitor Impedes Radioresistance of Colorectal Cancer Cells with Decreased ALDH1L2 Expression Via TXN/NF-κB Signaling Pathway**  
   *British Journal of Cancer* (2022, IF=9.1, Q2). ​**Co-first author (first position)**.  
2. ​**Histone Methyltransferase SETDB1 Promotes Colorectal Cancer Proliferation through the STAT1-CCND1/CDK6 Axis**  
   *Carcinogenesis* (2020, IF=4.9, Q3). ​**Co-first author (first position)**.  
3. ​**CPT1A Mediates Radiation Sensitivity in Colorectal Cancer**  
   *eLife* (2024, IF=6.4, Q1 TOP). ​**Co-first author (second position)**.  
4. ​**Gut microbiota dynamics and fecal SCFAs after colonoscopy: accelerating microbiome stabilization by Clostridium butyricum**  
   *Journal of Translational Medicine* (2024, IF=6.1, Q2). ​**Co-first author (second position)**.  
5. ​**Bioinformatic identification of key pathways, hub genes, and microbiota for therapeutic intervention in Helicobacter pylori infection**  
   *Journal of Cellular Physiology* (2021, IF=6.5, Q2). ​**Co-first author (third position)**.  

#### ​**Patents**  
- ​**Granted**:  
  1. *Method for constructing colorectal cancer model based on 5hmC biomarkers* (ZL 202210250395.5, 2nd inventor, 2022).  
  2. *Lacticaseibacillus rhamnosus DY801 strain and applications* (ZL 202211621368.0, 2nd inventor, 2023).  
  3. *Salivarius Lactobacillus DY802 strain and applications* (ZL 202211621413.2, 3rd inventor, 2023).  
  4. *Limosilactobacillus fermentum CYQ09 strain and applications* (ZL 202211621377.X, 3rd inventor, 2023).  
  5. *AI-assisted diagnostic system for gastrointestinal tumors* (ZL 202311368699.2, 2nd inventor, 2024).  
- ​**Utility Model Patent**:  
  *Mouse irradiation mold for X-ray experiments* (ZL 201822268723.6, 5th inventor, 2019).  
- ​**International Applications**:  
  *Lacticaseibacillus rhamnosus DY801* (Australia: PY-AU-24031; U.S.: PY-US-24030, 2nd inventor).  

---

### Honors & Awards  
1. National Scholarship (2018-2019)  
2. Outstanding Graduate Student, Southern Medical University (2018-2019, 2021-2022)  
3. Outstanding Graduate, Southern Medical University (2020, 2023)  
4. First-Class Academic Scholarship, Southern Medical University (2021-2022)  

---

### Conference Presentations  
- ​**Oral Presentations**:  
  1. China Gut Conference (2023, Beijing)  
  2. 12th National Conference on Radiation & Environmental Biophysics (2023, Shantou)  
  3. CSTRO Gastrointestinal Symposium (2023, Shanghai)  
  4. 19th CSTRO Annual Meeting (2024, Beijing)  
- ​**Poster Presentations**:  
  1. International Digestive Disease Forum (IDDF 2023/2024, Hong Kong; *Gut* abstract)  
  2. ASTRO Annual Meeting (2024, San Diego)  
  3. ASM Microbe (2024, Atlanta)  
- ​**Travel Award**: IDDF 2023 (Hong Kong).  
- ​**ASCO 2024**: Abstract published in *Journal of Clinical Oncology*.  

---

### Mentorship  
- ​**China International College Students' Innovation Competition**  
  - Provincial Silver Award (Guangdong, 2024)  
  - University Silver Award (Southern Medical University, 2024)  

---

### Funded Projects  
- ​**National Natural Science Foundation of China (NSFC)**: 3 General Programs (participant).  
- ​**Guangdong Provincial and Municipal Funds**: 3 projects (participant).  
